SPDR S&P Pharmaceuticals ETF
XPH
XPH
69 hedge funds and large institutions have $93.1M invested in SPDR S&P Pharmaceuticals ETF in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 17 closing their positions.
Holders
69
Holders Change
-9
Holders Change %
-11.54%
% of All Funds
1.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
19
Reduced
24
Closed
17
Calls
$420K
Puts
$756K
Net Calls
-$336K
Net Calls Change
+$84K
Top Buyers
1 |
FFM
1
Fullerton Fund Management
Singapore
|
$2.2M |
2 |
![]()
2
JPMorgan Chase & Co
New York
|
$2.73M |
3 |
AWM
3
AE Wealth Management
Topeka,
Kansas
|
$746K |
4 |
4
Jane Street
New York
|
$553K |
5 |
5
Millennium Management
New York
|
$327K |